[go: up one dir, main page]

BRPI0823254A2 - Complexos de inclusão de pinocembrina com ciclodextrina ou seus derivados - Google Patents

Complexos de inclusão de pinocembrina com ciclodextrina ou seus derivados

Info

Publication number
BRPI0823254A2
BRPI0823254A2 BRPI0823254-7A BRPI0823254A BRPI0823254A2 BR PI0823254 A2 BRPI0823254 A2 BR PI0823254A2 BR PI0823254 A BRPI0823254 A BR PI0823254A BR PI0823254 A2 BRPI0823254 A2 BR PI0823254A2
Authority
BR
Brazil
Prior art keywords
pinocembrin
cyclodextrin
derivatives
inclusion complexes
complexes
Prior art date
Application number
BRPI0823254-7A
Other languages
English (en)
Inventor
Song Wu
Guanhua Du
Yan Qi
Mei Gao
Qingyun Yang
Hongmei Guang
We Li
Yuehua Wang
Yuanfeng Tong
Original Assignee
Inst Materia Medica Cams
Cspc Zhongqi Pharmaceutical Technology Shijiazhuan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Materia Medica Cams, Cspc Zhongqi Pharmaceutical Technology Shijiazhuan filed Critical Inst Materia Medica Cams
Publication of BRPI0823254A2 publication Critical patent/BRPI0823254A2/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40Cyclodextrins; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82YSPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00Preparations for use in therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nanotechnology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Dermatology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
BRPI0823254-7A 2008-11-11 2008-11-11 Complexos de inclusão de pinocembrina com ciclodextrina ou seus derivados BRPI0823254A2 (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/CN2008/073011 WO2010054507A1 (zh) 2008-11-11 2008-11-11 松属素环糊精或环糊精衍生物包合物

Publications (1)

Publication Number Publication Date
BRPI0823254A2 true BRPI0823254A2 (pt) 2015-06-23

Family

ID=42169585

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0823254-7A BRPI0823254A2 (pt) 2008-11-11 2008-11-11 Complexos de inclusão de pinocembrina com ciclodextrina ou seus derivados

Country Status (16)

Country Link
US (1) US9949946B2 (pt)
EP (1) EP2359861B1 (pt)
JP (1) JP5413998B2 (pt)
KR (1) KR101563308B1 (pt)
AP (1) AP2011005707A0 (pt)
AU (1) AU2008364165B2 (pt)
BR (1) BRPI0823254A2 (pt)
CA (1) CA2743006C (pt)
CU (1) CU24034B1 (pt)
EA (1) EA020784B1 (pt)
ES (1) ES2438294T3 (pt)
IL (2) IL212819A (pt)
MX (1) MX2011004991A (pt)
UA (1) UA99979C2 (pt)
WO (1) WO2010054507A1 (pt)
ZA (1) ZA201103244B (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AP2011005766A0 (en) * 2008-12-11 2011-06-30 Cspc Zhongqi Pharmaceutical Technology Shijiazhuang Ltd Use of racemates of pinocembrin in preparing medicaments for treating stroke.
GR1007520B (el) * 2010-12-02 2012-02-02 Apivita - Καλλυντικα - Διαιτητικα - Φαρμακα Ανωνυμη Εμπορικη Και Βιοτεχνικη Εταιρεια, Ταυτοχρονη εκχυλιση και σχηματισμος συμπλοκων εγκλεισμου των δραστικων συστατικων της προπολης με υδροξυπροπυλο-β-κυκλοδεξτρινη
CN104270945B (zh) 2012-03-19 2017-03-29 巴克老龄化研究所 App特异性bace抑制剂(asbi)及其用途
WO2014127042A1 (en) 2013-02-12 2014-08-21 Buck Institute For Research On Aging Hydantoins that modulate bace-mediated app processing
WO2019046126A1 (en) 2017-08-28 2019-03-07 Achaogen, Inc. Aminoglycosides and uses thereof
US11673907B2 (en) 2018-04-03 2023-06-13 Revagenix, Inc. Modular synthesis of aminoglycosides
KR102705165B1 (ko) 2019-01-22 2024-09-11 에오비안 파마슈티컬스, 인크. Mtorc 조절제 및 이의 용도
KR102356618B1 (ko) * 2021-11-17 2022-02-08 명지대학교 산학협력단 신규 포접복합체 및 이의 용도
AU2023228405A1 (en) 2022-03-04 2024-10-10 Revagenix, Inc. Broad spectrum aminoglycosides and uses thereof

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8904296D0 (sv) * 1989-12-21 1989-12-21 Pharmacia Ab Transdermal system
JP3269737B2 (ja) * 1994-08-31 2002-04-02 宇野醤油株式会社 食品保存料、およびその製造方法
JP2782335B2 (ja) * 1996-03-04 1998-07-30 株式会社武田薬化学研究所 プロポリスの水分散液
CN1424112A (zh) * 2002-12-17 2003-06-18 上海医药工业研究院 难溶性药物的水溶性包合物及其制备方法
CN1285334C (zh) 2004-05-12 2006-11-22 中国医学科学院药物研究所 生松素在制备防治神经细胞损伤相关疾病药物中的应用
WO2006020163A1 (en) * 2004-07-23 2006-02-23 The Procter & Gamble Company Skin care composition containing a flavonoid and vitamin b3
CN1739537A (zh) 2004-08-26 2006-03-01 张红军 灯盏花素环糊精包合物及其制剂
KR100601395B1 (ko) * 2004-11-04 2006-07-18 한국식품연구원 수용성 프로폴리스 추출물 및 분말의 제조 방법
CN1311815C (zh) * 2005-05-08 2007-04-25 浙江大学 亚微米蜂胶微胶囊的制备方法
CN1879656B (zh) 2006-04-27 2010-04-21 魏春华 固体水溶性蜂胶组合物及其制备方法

Also Published As

Publication number Publication date
IL212819A (en) 2015-07-30
AU2008364165A1 (en) 2010-05-20
IL212819A0 (en) 2011-07-31
KR101563308B1 (ko) 2015-10-26
US20110218173A1 (en) 2011-09-08
EA201100730A1 (ru) 2011-10-31
JP2012508191A (ja) 2012-04-05
EA020784B1 (ru) 2015-01-30
MX2011004991A (es) 2011-07-29
CU24034B1 (es) 2014-10-02
ZA201103244B (en) 2011-12-28
ES2438294T3 (es) 2014-01-16
CU20110103A7 (es) 2012-01-31
US9949946B2 (en) 2018-04-24
KR20110098906A (ko) 2011-09-02
EP2359861A4 (en) 2012-05-02
HK1155094A1 (en) 2012-08-03
EP2359861B1 (en) 2013-09-11
WO2010054507A1 (zh) 2010-05-20
CA2743006A1 (en) 2010-05-20
CA2743006C (en) 2016-02-09
AU2008364165B2 (en) 2015-01-29
JP5413998B2 (ja) 2014-02-12
AP2011005707A0 (en) 2011-06-30
UA99979C2 (uk) 2012-10-25
EP2359861A1 (en) 2011-08-24

Similar Documents

Publication Publication Date Title
BRPI0823254A2 (pt) Complexos de inclusão de pinocembrina com ciclodextrina ou seus derivados
BRPI0915991A2 (pt) derivados de sulfamida substituída
HRP20161576T1 (hr) Registarske tablice za vozilo
BRPI0813707A2 (pt) Derivados de pirimidinil-piridazinona
BRPI0820112A2 (pt) Derivados de isoxazol-piridina
BRPI0809992A2 (pt) Derivados de pirrolopirimidina
BRPI0820113A2 (pt) Derivados de isoxazolo-piridazina
BRPI0915064A2 (pt) derivados de qunoxalinadiona
BRPI0920278A2 (pt) artigo de fumo
BRPI0917557A2 (pt) artigo absorvente com componente de barreira
BRPI0812155A2 (pt) derivados de espiroindolinona
BRPI0817935A2 (pt) Derivados de biarila
BRPI0913832A2 (pt) derivados de pirrolopiridinilpirimidin-2-ilamina
BRPI0720220A2 (pt) Derivados de quinolinas antibacterianos
BRPI0814236A2 (pt) Derivados de quinazolinamida
BRPI0812518A2 (pt) Derivados de indazolamida
BRPI0820649A2 (pt) Derivados de isoxazalo-pirazina
BRPI0816829A2 (pt) Indicador de posição de eixo rotativo
EP2144635A4 (en) STERILIZING COMPOSITION
BRPI0912097A2 (pt) braço de suspensão de veículo
ATE510152T1 (de) Verbesserte differenzialhalteringanordnung
BRPI0917446A2 (pt) derivados de acilaminobenzamida.
BRPI0913234A2 (pt) derivados de tiazolilpiperidina
BRPI0922652A2 (pt) Derivados de quinazolinamida
BRPI0906714A2 (pt) Derivados de oxazepinopirimidona heteroarilamida substituídos.

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL